COSCIENS Biopharma Stock Forecast - Accumulation Distribution
| CSCI Stock | 3.13 0.04 1.29% |
COSCIENS Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of COSCIENS Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
COSCIENS |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 500.85 | 752.92 |
| Check COSCIENS Biopharma Volatility | Backtest COSCIENS Biopharma | Trend Details |
COSCIENS Biopharma Trading Date Momentum
| On September 30 2024 COSCIENS Biopharma was traded for 3.75 at the closing time. The top price for the day was 3.80 and the lowest listed price was 3.75 . The trading volume for the day was 800. The trading history from September 30, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.32% . The overall trading delta against the current closing price is 2.11% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare COSCIENS Biopharma to competition |
Other Forecasting Options for COSCIENS Biopharma
For every potential investor in COSCIENS, whether a beginner or expert, COSCIENS Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. COSCIENS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in COSCIENS. Basic forecasting techniques help filter out the noise by identifying COSCIENS Biopharma's price trends.COSCIENS Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with COSCIENS Biopharma stock to make a market-neutral strategy. Peer analysis of COSCIENS Biopharma could also be used in its relative valuation, which is a method of valuing COSCIENS Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
COSCIENS Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of COSCIENS Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of COSCIENS Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
COSCIENS Biopharma Market Strength Events
Market strength indicators help investors to evaluate how COSCIENS Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading COSCIENS Biopharma shares will generate the highest return on investment. By undertsting and applying COSCIENS Biopharma stock market strength indicators, traders can identify COSCIENS Biopharma entry and exit signals to maximize returns.
COSCIENS Biopharma Risk Indicators
The analysis of COSCIENS Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in COSCIENS Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cosciens stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.09 | |||
| Standard Deviation | 3.04 | |||
| Variance | 9.25 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether COSCIENS Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of COSCIENS Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cosciens Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cosciens Biopharma Stock:Check out Historical Fundamental Analysis of COSCIENS Biopharma to cross-verify your projections. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of COSCIENS Biopharma. If investors know COSCIENS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 3.759 | Quarterly Revenue Growth 0.041 | Return On Assets (0.23) | Return On Equity (0.66) |
The market value of COSCIENS Biopharma is measured differently than its book value, which is the value of COSCIENS that is recorded on the company's balance sheet. Investors also form their own opinion of COSCIENS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is COSCIENS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because COSCIENS Biopharma's market value can be influenced by many factors that don't directly affect COSCIENS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between COSCIENS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if COSCIENS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSCIENS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.